Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 143,398 | 170,022 | 167,594 | 164,623 | 122,298 |
Receivables | 922,513 | 947,738 | 881,967 | 962,864 | 973,068 |
Inventories | 98,331 | 97,363 | 95,234 | 92,447 | 96,839 |
Income taxes - deferred | 161,182 | 153,630 | 149,841 | 141,554 | 135,806 |
TOTAL | $1,417,088 | $1,464,635 | $1,374,357 | $1,449,246 | $1,415,201 |
Non-Current Assets | |||||
PPE Net | 893,073 | 906,097 | 911,998 | 891,540 | 888,874 |
Intangibles | 6,093,403 | 6,113,751 | 6,106,837 | 6,072,577 | 6,029,492 |
Other Non-Current Assets | 163,468 | 161,851 | 172,501 | 169,268 | 160,466 |
TOTAL | $7,149,944 | $7,181,699 | $7,191,336 | $7,133,385 | $7,078,832 |
Total Assets | $8,567,033 | $8,646,334 | $8,565,693 | $8,582,631 | $8,494,033 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 50,364 | 48,792 | 163,581 | 292,382 | 367,103 |
Accounts payable and accrued liabilities | 1,080,236 | 1,143,937 | 1,124,716 | 910,593 | 792,449 |
TOTAL | $1,130,600 | $1,192,729 | $1,288,297 | $1,202,975 | $1,159,552 |
Non-Current Liabilities | |||||
Long Term Debt | 3,209,298 | 3,378,715 | 3,377,212 | 3,471,755 | 3,545,043 |
aiOther Non-Current Liabilities | 551,655 | 565,809 | 575,942 | 579,831 | 600,111 |
TOTAL | $3,768,779 | $3,951,578 | $3,953,154 | $4,051,586 | $4,145,154 |
Total Liabilities | $4,899,379 | $5,144,307 | $5,241,451 | $5,254,561 | $5,304,706 |
Shareholders' Equity | |||||
Shares Outstanding, K | 195,132 | 194,828 | 194,149 | 193,604 | 193,142 |
Common Shares | 2,141 | 2,141 | 2,137 | 2,138 | 2,137 |
Retained earnings | 2,319,730 | 2,177,908 | 2,057,744 | 2,082,401 | 2,003,795 |
Other shareholders' equity | 47,437 | 52,115 | 25,536 | 34,505 | 5,382 |
TOTAL | $3,667,654 | $3,502,027 | $3,324,242 | $3,328,070 | $3,189,327 |
Total Liabilities And Equity | $8,567,033 | $8,646,334 | $8,565,693 | $8,582,631 | $8,494,033 |